DMS Group Publishes Liquidity Contract Report as of December 31, 2025
Diagnostic Medical Systems has reported the semi-annual review of its liquidity contract managed by Natixis ODDO BHF, covering the period from July 1 to December 31, 2025.
Liquidity Account Status
As of December 31, 2025, the dedicated liquidity account displayed a position of 110,630 securities and 102,349 euros, the group reports. At the initiation of the contract on May 7, 2025, the allocated resources amounted to 150,000 securities and 50,000 euros. The change in position reflects the regulatory activity on the stock in the market during the first seven months of the contract.
Transaction Details
During the period from July 1 to December 31, 2025, the service provider executed 1,155 purchase transactions and 1,153 sale transactions, according to the statement. The traded volumes amounted to 248,152 securities for 330,540 euros in purchases, versus 253,627 securities for 342,117 euros in sales. The difference between purchases and sales indicates a slight net selling position over the semester.
Future Financial Announcements
DMS Group plans to publish its annual revenue for 2025 on January 19, 2026, followed by the annual results for 2025 on April 14, 2026. The revenue for the first quarter of 2026 will be revealed on April 21, 2026. The company notes that this provisional schedule is subject to change. In 2024, the group specializing in medical imaging systems reported consolidated revenue of 46.1 million euros, with more than 75% generated internationally.
